Gilead Sciences Reports Strong Q4 Earnings Growth

Gilead Sciences showcased strong results in its latest earnings report, with a notable increase in both earnings and revenue year-over-year. The company reported earnings totaling $1.7 billion, reflecting positive trends in its financial performance.

Date: 12-02-2025

AI Rating: 7

Earnings Per Share (EPS): Gilead Sciences reported earnings of $1.7 billion, equating to an EPS of $1.42. This is an improvement from $1.14 per share in the same period last year, indicating a strong performance and growth in profitability.

Revenue Growth: The company achieved a revenue increase of 5.6%, rising from $7.2 billion in the previous year to $7.6 billion this year. This growth suggests a healthy demand for Gilead’s products.

These improvements in EPS and revenue showcase Gilead's effective management and operational efficiency, which may enhance investor confidence and positively impact stock prices.

Stocks: GILD